Immunohistochemical characteristics of breast cancer, increasing the risk of local reccurence after organosaving treatment
- Authors: Demidov S.M.1,2, Demidov D.A.1,2, Sazonov S.V.1,3, Churakova E.I.1
-
Affiliations:
- Urals State Medical University, Ministry of Health of Russia
- City Clinical Hospital No. 40
- Institute of Medical Cell Technologies
- Issue: Vol 14, No 3 (2018)
- Pages: 10-14
- Section: MAMMOLOGY. ORIGINAL REPORTS
- Published: 14.10.2018
- URL: https://ojrs.abvpress.ru/ojrs/article/view/601
- DOI: https://doi.org/10.17650/1994-4098-2018-14-3-10-14
- ID: 601
Cite item
Full Text
Abstract
Objective: an immunohistochemical analysis of the characteristics of a recurrent tumor in breast cancer. Materials and methods. The statistical processing of immunohistochemical analysis’ results was performed and the most frequently encountered molecular-genetic subtypes of breast cancer with the development of local relapses were formulated. The analysis used a standard immunohistochemical panel, which is the “gold standard” for diagnostic in Russia today, and includes the expression of receptors for sex hormones (estrogen and progesterone), expression of the human epidermal growth factor HER2/neu receptor gene, and the index of proliferative activity Ki-67. The 2nd stage of the work was the evaluation of the dynamics of changes in the immunohistochemical characteristics of a recurrent tumor in comparison with the primary one. Results and conclusion. The most common local recurrence provides by triple-negative subtype of breast cancer (42 %). The changes in the immunohistochemical characteristics of a recurrent tumor in comparison with the primary one affected only the index of proliferative activity Ki-67 in the direction of its increase by 12 %.
About the authors
S. M. Demidov
Urals State Medical University, Ministry of Health of Russia; City Clinical Hospital No. 40
3 Repina St., 620219 Ekaterinburg
189 Volgogradskaya St., 620102 Ekaterinburg
D. A. Demidov
Urals State Medical University, Ministry of Health of Russia; City Clinical Hospital No. 40
Author for correspondence.
Email: p18193@gmail.com
3 Repina St., 620219 Ekaterinburg
189 Volgogradskaya St., 620102 Ekaterinburg
S. V. Sazonov
Urals State Medical University, Ministry of Health of Russia; Institute of Medical Cell Technologies
3 Repina St., 620219 Ekaterinburg
22а Karla Marksa St., 620026 Ekaterinburg
E. I. Churakova
Urals State Medical University, Ministry of Health of Russia
3 Repina St., 620219 Ekaterinburg
Russian Federation
References
Supplementary files

